摘要 |
<p>The present invention involves a method of exploiting a novel apolipoprotein-B (apoB) degradation pathway to regulate plasma levels of apoB to treat cardiovascular or metabolic disorders or syndromes, a method of exploiting a novel apoliprotein-B (apoB) degradation pathway to diagnose cardiovascular or metabolic disorders or syndromes, a method of exploiting a novel apolipoprotein-B (apoB) degradation to screen for drugs to treat cardiovascular or metabolic disorders or syndromes, and a method of exploiting a novel apoliprotein-B (apoB) degradation pathway to screen for genes for diagnosing cardiovascular or metabolic disorders or syndromes.</p> |